Thrombocythemia | Symptoms, Risk Groups & Treatment Options

 Home > Drugs > Thrombocythemia

Thrombocythemia

Primary thrombocythemia is a myeloproliferative disease characterized by bleeding tendency and thrombosis, a continuous and significant increase in peripheral blood platelets, abnormal function, and excessive proliferation of bone marrow megakaryocytes. Since this disease often causes repeated bleeding, it is also called hemorrhagic thrombocythemia. The incidence rate is not high, and it is more common in people over 40 years old. Thrombocythemia can be divided into primary and secondary types. Primary or idiopathic thrombocythemia is a type of myeloproliferative disease. Most patients are adults, and it is extremely rare in children. About 5% of children may develop acute leukemia.

Site of disease:

Blood vessels
Infectious :

Not contagious
Frequent population:

Mostly seen in people over 40 years old
Related symptoms:

Thrombocytosis Bleeding tendency Microthrombosis Splenomegaly Dizziness
Concurrent disease:

Secondary thrombocythemia Elderly essential thrombocythemia Childhood secondary thrombocythemia Childhood essential thrombocythemia Essential thrombocythemia

Related Drugs

Busulfan Tablets

Indication: It is mainly used in the chronic phase of chronic myeloid leukemia, and has poor effects on patients lacking the Philadelphia chromosome Ph1. It can also be used to treat chronic myeloproliferative diseases such as essential thrombocythemia and polycythemia vera.

Busulfan Injection

Sodium phosphate [32P] salt oral solution